Trial intelligence / Profile preview

Dr. Wolff Mouth Gel vs Biotène Oralbalance in Xerostomia

DRKS00013281Phase 4Completed

Sponsor
Uniklinik Köln
Start
Dec 2017
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of Dr. Wolff Mouth Gel and Biotène Oralbalance Mouth Gel in xerostomia (2 arms), sponsored by Uniklinik Köln. Primary endpoint: Subjective symptom relief of xerostomia. Started Dec 2017; status: completed.

02

Drugs

Dr. Wolff Mouth GelBiotène Oralbalance Mouth Gel
03

Conditions

xerostomia

Beyond the preview

Go deeper on DRKS00013281.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00013281.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call